AR029001A1 - Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento - Google Patents
Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamentoInfo
- Publication number
- AR029001A1 AR029001A1 ARP000104301A ARP000104301A AR029001A1 AR 029001 A1 AR029001 A1 AR 029001A1 AR P000104301 A ARP000104301 A AR P000104301A AR P000104301 A ARP000104301 A AR P000104301A AR 029001 A1 AR029001 A1 AR 029001A1
- Authority
- AR
- Argentina
- Prior art keywords
- aryl
- alkyl
- heteroaryl
- group
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/60—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Abstract
Derivados bencil û 3, 4 û metilendioxicinamico, que comprende un compuesto de acuerdo con la formula 1 donde R1 es arilo o heteroarilo; R2 se selecciona del grupo constituido por O (CH2)m û arilo, O (CH2)m û heteroarilo, N (R5) (CH2)m û arilo, N (R5) (CH2)m- heteroarilo, N (R6) CO û arilo, N (R6) CO ûheteroarilo, N (R6) SO2 û arilo y N (R6) SO2- heteroarilo; R3 se selecciona del grupo constituido por H, alquilo C1-8, alquil C1-3 ûarilo, CO alquilo (C1-8), y CO arilo; R4 se selecciona del grupo constituido por H, alquilo C1-8 y alquil C1-3-arilo; y X e Y se seleccionan independientemente del grupo que constituido por H, Cl, CH3 y OCH3; y m es un numero entero de 0 a 3 o una de sus sales farmacéuticamente aceptables, o uno de sus complejos de sales farmacéuticamente aceptables; y se refiere al uso de compuestos para la manufactura de un medicamento como inhibidores de la sintetasa de los ácidos grasos FabH para tratar infecciones bacterianas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15027799P | 1999-08-23 | 1999-08-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR029001A1 true AR029001A1 (es) | 2003-06-04 |
Family
ID=22533810
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP000104301A AR029001A1 (es) | 1999-08-23 | 2000-08-18 | Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento |
Country Status (20)
Country | Link |
---|---|
US (1) | US6559179B1 (es) |
EP (1) | EP1206465A4 (es) |
JP (1) | JP2003507469A (es) |
KR (1) | KR20020033767A (es) |
CN (1) | CN1370158A (es) |
AR (1) | AR029001A1 (es) |
AU (1) | AU6935900A (es) |
BR (1) | BR0013515A (es) |
CA (1) | CA2384197A1 (es) |
CZ (1) | CZ2002638A3 (es) |
HK (1) | HK1047927A1 (es) |
HU (1) | HUP0202457A3 (es) |
IL (1) | IL148324A0 (es) |
MX (1) | MXPA02001821A (es) |
NO (1) | NO20020609L (es) |
NZ (1) | NZ517322A (es) |
PL (1) | PL364920A1 (es) |
TR (1) | TR200200494T2 (es) |
WO (1) | WO2001014364A1 (es) |
ZA (1) | ZA200201426B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101117328B (zh) * | 2006-08-01 | 2012-11-07 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其用于治疗细菌感染的用途 |
CN101190904A (zh) * | 2006-11-23 | 2008-06-04 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸合成酶抑制剂及其制药用途 |
CN101450912B (zh) * | 2007-11-24 | 2012-05-30 | 山东轩竹医药科技有限公司 | 四氢化萘取代的苯甲酸衍生物 |
CN101450911B (zh) * | 2007-11-30 | 2012-02-29 | 山东轩竹医药科技有限公司 | 被金刚烷取代的苯甲酸衍生物 |
WO2011140296A1 (en) | 2010-05-05 | 2011-11-10 | Infinity Pharmaceuticals | Triazoles as inhibitors of fatty acid synthase |
EP3159331A1 (en) | 2010-05-05 | 2017-04-26 | Infinity Pharmaceuticals, Inc. | Tetrazolones as inhibitors of fatty acid synthase |
CN102675211A (zh) * | 2011-03-17 | 2012-09-19 | 南京大学 | 塞克硝唑肉桂酸酯衍生物的合成及其在抗菌药物方面的应用 |
RS59411B1 (sr) | 2013-03-13 | 2019-11-29 | Forma Therapeutics Inc | Derivati 2-hidroksi-1-{4-[(4-fenilfenil)karbonil]piperazin-1-il}etan-1-ona i srodna jedinjenja kao inhibitori sintaze masnih kiselina (fasn) za lečenje kancera |
US10966981B2 (en) | 2016-04-21 | 2021-04-06 | Duke University | Fatty acid synthase inhibitors |
TWI767148B (zh) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | 抑制脂肪酸合成酶(fasn) |
WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676052B1 (fr) * | 1991-05-02 | 1994-04-29 | Cird Galderma | Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique. |
US5369127A (en) * | 1993-04-21 | 1994-11-29 | Allergan, Inc. | 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
-
2000
- 2000-08-18 AR ARP000104301A patent/AR029001A1/es not_active Application Discontinuation
- 2000-08-23 CN CN00811896A patent/CN1370158A/zh active Pending
- 2000-08-23 TR TR2002/00494T patent/TR200200494T2/xx unknown
- 2000-08-23 JP JP2001518451A patent/JP2003507469A/ja not_active Withdrawn
- 2000-08-23 IL IL14832400A patent/IL148324A0/xx unknown
- 2000-08-23 KR KR1020027002280A patent/KR20020033767A/ko not_active Application Discontinuation
- 2000-08-23 HU HU0202457A patent/HUP0202457A3/hu unknown
- 2000-08-23 MX MXPA02001821A patent/MXPA02001821A/es not_active Application Discontinuation
- 2000-08-23 NZ NZ517322A patent/NZ517322A/en not_active IP Right Cessation
- 2000-08-23 AU AU69359/00A patent/AU6935900A/en not_active Abandoned
- 2000-08-23 PL PL00364920A patent/PL364920A1/xx not_active Application Discontinuation
- 2000-08-23 CZ CZ2002638A patent/CZ2002638A3/cs unknown
- 2000-08-23 US US10/049,353 patent/US6559179B1/en not_active Expired - Lifetime
- 2000-08-23 EP EP00957791A patent/EP1206465A4/en not_active Withdrawn
- 2000-08-23 WO PCT/US2000/023324 patent/WO2001014364A1/en active IP Right Grant
- 2000-08-23 CA CA002384197A patent/CA2384197A1/en not_active Abandoned
- 2000-08-23 BR BR0013515-1A patent/BR0013515A/pt not_active Application Discontinuation
-
2002
- 2002-02-07 NO NO20020609A patent/NO20020609L/no not_active Application Discontinuation
- 2002-02-20 ZA ZA200201426A patent/ZA200201426B/en unknown
- 2002-10-24 HK HK02107739.9A patent/HK1047927A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
CA2384197A1 (en) | 2001-03-01 |
HUP0202457A2 (en) | 2002-10-28 |
US6559179B1 (en) | 2003-05-06 |
EP1206465A1 (en) | 2002-05-22 |
IL148324A0 (en) | 2002-09-12 |
CN1370158A (zh) | 2002-09-18 |
MXPA02001821A (es) | 2002-08-06 |
CZ2002638A3 (cs) | 2002-05-15 |
BR0013515A (pt) | 2002-05-07 |
HUP0202457A3 (en) | 2003-03-28 |
TR200200494T2 (tr) | 2003-02-21 |
PL364920A1 (en) | 2004-12-27 |
WO2001014364A1 (en) | 2001-03-01 |
EP1206465A4 (en) | 2003-01-02 |
NO20020609D0 (no) | 2002-02-07 |
ZA200201426B (en) | 2003-11-26 |
AU6935900A (en) | 2001-03-19 |
JP2003507469A (ja) | 2003-02-25 |
HK1047927A1 (zh) | 2003-03-14 |
NO20020609L (no) | 2002-02-07 |
KR20020033767A (ko) | 2002-05-07 |
NZ517322A (en) | 2003-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
AR033499A1 (es) | Derivado de quinazolina, proceso para su preparacion, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para usar en la produccion de un efecto antiangeogenico y/o reductor de la permeabilidad vascular en un animal de sangre caliente | |
EA200501098A1 (ru) | Антибактериальные агенты | |
BR0108893B1 (pt) | composiÇço farmacÊutica contendo derivados de azetidina, composto derivado de azetidina, e, processo para a preparaÇço de compostos. | |
DE60132309D1 (de) | Amin-derivate zur behandlung von apoptosis | |
EA200100983A1 (ru) | Производные 13-метилэритромицина | |
CO4810375A1 (es) | Derivados de 9-amino-3-ceto eritromicina | |
EA200401053A1 (ru) | Оксо-азабициклические соединения | |
AR038818A1 (es) | Compuesto de piperidina, uso del mismo para preparar un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion | |
DZ1694A1 (fr) | "n-(2-Aminoethyl)-benzothialozones". | |
AR029001A1 (es) | Derivados de bencil-3,4-metilendioxicinamico y el uso de los mismos para la manufactura de un medicamento | |
AR032617A1 (es) | Utilizacion de derivados de biguanida para fabricar un medicamento que tiene un efecto cicatrizante | |
DK0992509T3 (da) | Nye makrolid-derivater | |
EA200100090A2 (ru) | Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции | |
PT1216245E (pt) | Derivados sulfonil-hidrazida farmaceuticamente activos | |
DK1109560T3 (da) | Som AICARFT-inhibitorer anvendelige forbindelser | |
ATE344230T1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
EA200100969A1 (ru) | Новые соединения циклобутендиона, способ их получения и содержащие их фармацевтические композиции | |
FR2707089B1 (fr) | Nouveaux dérivés d'acide phosphonique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. | |
AR035599A1 (es) | Compuestos 1,8-naftiridina, dihidroquinolina y piridol[1,2,3-de][1,4]benzoxazina sustituidos, medicamentos, agentes terapeuticos, metodos de produccion y usos en la produccion de un medicamento, de un agente antibacteriano y de un agente para tratar una enfermedad infecciosa | |
AR038197A1 (es) | Acidos 3-(imidazolil)-2-alcoxipropanoicos, procedimientos para la preparacion de los mismos, composiciones farmaceuticas de los mismos y uso de los mismos en la preparacion de medicamentos | |
EA200000374A2 (ru) | Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции | |
AR044320A1 (es) | Derivados 3-decladinosilo de la clase de 9a - n-carbamoil - y 9a-ntiocarbamoil- 9 dihidro-9a aza- 9a - homoeritromicina a | |
EA200100725A3 (ru) | Новые бензотиадиазиновые соединения, способ их получения и их содержащие фармацевтические композиции | |
PA8450901A1 (es) | Derivados de eritromicina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |